MATHYM Overview

  • Founded
  • 2013

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees
  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $5.94M

MATHYM General Information

Description

Developer of nano-dispersions intended to specialize in the field of biomedical applications. The company's nano-dispersions bring or reinforce critical properties within medical devices that ensure a steady and homogeneous dispersion of nanoparticles in liquid, enabling researchers to research in an enhanced way.

Contact Information

Website
www.mathym.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Parent Company
Baikowski
Primary Office
  • 22, rue des Aulnes
  • 69410 Champagne-au-Mont-d'Or
  • France
+33 04 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MATHYM Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 30-Sep-2019 $5.94M 00.000 00.000 Completed Generating Revenue
4. Early Stage VC 13-Oct-2016 00.000 00.000 00.000 Completed Generating Revenue
3. Debt - General 14-Apr-2016 00000 00.000 Completed Generating Revenue
2. Grant 01-Jul-2014 $823K Completed Generating Revenue
1. Seed Round 01-Jun-2014 $823K $823K 00.000 Completed Generating Revenue
To view MATHYM’s complete valuation and funding history, request access »

MATHYM Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
P 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
P 0,000 00.000000 000.00 000.00 00 000.00 00.000
O 10,000 $1.118615
To view MATHYM’s complete cap table history, request access »

MATHYM Patents

MATHYM Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3089136-A1 Process for the preparation of zirconium dioxide nanoparticles in the presence of amino acid Pending 30-Nov-2018 000000000 0
EP-3887316-A1 Method for producing zirconium dioxide nanoparticles in the presence of an amino acid Pending 30-Nov-2018 000000000
EP-3538258-B1 Colloidal suspension of functionalised nanoparticles of a fluoride of an alkaline-earth element Active 14-Nov-2016 00000000000
FR-3058647-B1 Colloidal suspension of functionalized alkalino-earth element fluoride nanoparticles Active 14-Nov-2016 00000000000
FR-3058647-A1 Colloidal suspension of functionalized alkalino-earth element fluoride nanoparticles Granted 14-Nov-2016 B01J13/0017 0
To view MATHYM’s complete patent history, request access »

MATHYM Executive Team (5)

Name Title Board Seat Contact Info
Julien Alberici Co-Founder, Chief Executive Officer and Director General
Wilfried Mercadé Chief Technology Officer
Karine Landry Business Development Director
Morgann Donney Finance and Administration Manager
You’re viewing 4 of 5 executive team members. Get the full list »

MATHYM Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MATHYM Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Banexi Ventures Partners Venture Capital Minority 000 0000 000000 0
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
InnovationFund University Minority 000 0000 000000 0
Kreaxi Venture Capital Minority 000 0000 000000 0
OCTALFA Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »